Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis

Affiliations

• ¹ University of California San Francisco Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. Electronic address: Michael.reid@ucsf.edu.
• ² Global TB Community Advisory Board, Abidjan, Côte d'Ivoire, Yenepoya Medical College, Mangalore, India.
• ³ School of Public Health, Faculty of Medicine, Imperial College London, London, UK.
• ⁴ University of California San Francisco Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
• ⁵ Department of General Medicine, Yenepoya Medical College, Mangalore, India.
• ⁶ Department of Community Medicine, Yenepoya Medical College, Mangalore, India.
• ⁷ Division of Tuberculosis, Bureau of Global Health, USAID, Washington, DC, USA.
• ⁸ School of Medicine, University of California, Irvine, CA, USA.
• ⁹ Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
• ¹⁰ Bill and Melinda Gates Foundation, Seattle, WA, USA.
• ¹¹ Aurum Institute, Johannesburg, South Africa.
• ¹² Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
• ¹³ Heidelberg University Hospital, German Center of Infection Research, Heidelberg, Germany.
• ¹⁴ Stop TB Partnership, Geneva, Switzerland.
• ¹⁵ Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
• ¹⁶ Department of Medicine, Center for Global Health Practice and Impact, Georgetown University, Washington, DC, USA.
• ¹⁷ National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
• ¹⁸ Volunteer Health Services, Addis Ababa, Ethiopia.
• ¹⁹ KNCV Tuberculosis Foundation, The Haag, Netherlands.
• ²⁰ Treatment Action Group, New York, NY, USA.
• ²¹ Campaigns in Global Health, Cambridge, UK.
• ²² McGill International TB Centre, McGill University, Montreal, QC, Canada.
• ²³ Global TB Caucus, Houses of Parliament, London, UK.
• ²⁴ Global TB Community Advisory Board, Surabaya, Indonesia.
• ²⁵ University of California San Francisco Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.
• ²⁶ Interactive Research & Development, Karachi, Pakistan.
• ²⁷ Save the Children, Fairfield, CT, USA.
• ²⁸ Global TB Community Advisory Board, Kyiv, Ukraine.
• ²⁹ Resource Group for Education and Advocacy for Community Health (REACH), Chennai, India.
• ³⁰ Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; McGill International TB Centre, McGill University, Montreal, QC, Canada.
• ³¹ Centre for Multidisciplinary Research in Health Science, University of Milan, Milan, Italy.
• ³² Open Consultants, Berlin, Germany.
• ³³ Harvard TH Chan School of Public Health, Harvard University, Cambridge, MA, USA.
• ³⁴ Hyfe AI, Wilmington, DE, USA.
• ³⁵ Mayo Clinic, Rochester, MN, USA.
• ³⁶ WHO, Geneva, Switzerland.
• ³⁷ Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, London, UK.
• ³⁸ Blavatnik School of Government, University of Oxford, Oxford, UK.
• ³⁹ Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC, USA.
• ⁴⁰ Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.
• ⁴¹ M S Swaminathan Research Foundation (MSSRF), Chennai, India.